Jensen, R. B., Carreira, A. & Kowalczykowski, S. C. Purified human BRCA2 stimulates RAD51-mediated recombination. Nature 467, 678–683 (2010).
Bell, J. C., Dombrowski, C. C., Plank, J. L., Jensen, R. B. & Kowalczykowski, S. C. BRCA2 chaperones RAD51 to single molecules of RPA-coated ssDNA. Proc. Natl Acad. Sci. USA 120, e2221971120 (2023).
McCabe, N. et al. BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of poly(ADP-ribose) polymerase: an issue of potency. Cancer Biol. Ther. 4, 934–936 (2005).
Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917–921 (2005).
Fong, P. C. et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med. 361, 123–134 (2009).
Lord, C. J. & Ashworth, A. PARP inhibitors: synthetic lethality in the clinic. Science 355, 1152–1158 (2017).
Wooster, R. et al. Identification of the breast-cancer susceptibility gene Brca2. Nature 378, 789–792 (1995).
Phelan, C. M. et al. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat. Genet. 13, 120–122 (1996).
Tutt, A. & Ashworth, A. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol. Med. 8, 571–576 (2002).
Nyberg, T. et al. Prostate cancer risks for male BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Eur. Urol. 77, 24–35 (2020).
Wong, A. K., Pero, R., Ormonde, P. A., Tavtigian, S. V. & Bartel, P. L. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene Brca2. J. Biol. Chem. 272, 31941–31944 (1997).
Sharan, S. K. et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804–810 (1997).
Whelan, D. R. et al. Spatiotemporal dynamics of homologous recombination repair at single collapsed replication forks. Nat. Commun. 9, 3882 (2018).
Davies, A. A. et al. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol. Cell 7, 273–282 (2001).
Prakash, R., Zhang, Y., Feng, W. R. & Jasin, M. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb. Perspect. Biol. 7, a016600 (2015).
Anand, R., Ranjha, L., Cannavo, E. & Cejka, P. Phosphorylated CtIP functions as a co-factor of the MRE11–RAD50–NBS1 endonuclease in DNA end resection. Mol. Cell 64, 940–950 (2016).
Bryant, H. E. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 447, 346–346 (2007).
Sung, P. Catalysis of ATP-dependent homologous DNA pairing and strand exchange by yeast RAD51 protein. Science 265, 1241–1243 (1994).
Belan, O. et al. Visualization of direct and diffusion-assisted RAD51 nucleation by full-length human BRCA2 protein. Mol. Cell 83, 2925–2940 (2023).
Sung, P. & Robberson, D. L. DNA strand exchange mediated by a Rad51–Ssdna nucleoprotein filament with polarity opposite to that of Reca. Cell 82, 453–461 (1995).
Baumann, P., Benson, F. E. & West, S. C. Human RAD51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell 87, 757–766 (1996).
Ogawa, T., Yu, X., Shinohara, A. & Egelman, E. H. Similarity of the yeast Rad51 filament to the bacterial Reca filament. Science 259, 1896–1899 (1993).
Yu, X., Jacobs, S. A., West, S. C., Ogawa, T. & Egelman, E. H. Domain structure and dynamics in the helical filaments formed by RecA and Rad51 on DNA. Proc. Natl Acad. Sci. USA 98, 8419–8424 (2001).
Pellegrini, L. et al. Insights into DNA recombination from the structure of a RAD51–BRCA2 complex. Nature 420, 287–293 (2002).
Subramanyam, S., Ismail, M., Bhattacharya, I. & Spies, M. Tyrosine phosphorylation stimulates activity of human RAD51 recombinase through altered nucleoprotein filament dynamics. Proc. Natl Acad. Sci. USA 113, E6045–E6054 (2016).
Joo, C. et al. Real-time observation of RecA filament dynamics with single monomer resolution. Cell 126, 515–527 (2006).
Jimenez-Sainz, J. et al. BRCA2 BRC missense variants disrupt RAD51-dependent DNA repair. eLife 11, e79183 (2022).
Marsden, C. G. et al. The tumor-associated variant RAD51 G151D induces a hyper-recombination phenotype. PLoS Genet. 12, e1006208 (2016).
Yin, Y. et al. A basal-level activity of ATR links replication fork surveillance and stress response. Mol. Cell 81, 4243–4257 (2021).
Laspata, N., Muoio, D. & Fouquerel, E. Multifaceted role of PARP1 in maintaining genome stability through its binding to alternative DNA structures. J. Mol. Biol. 436, 168207 (2024).
Zandarashvili, L. et al. Structural basis for allosteric PARP-1 retention on DNA breaks. Science 368, eaax6367 (2020).
Adolph, M. B. et al. RADX controls RAD51 filament dynamics to regulate replication fork stability. Mol. Cell 81, 1074–1083 (2021).
Simandlova, J. et al. FBH1 helicase disrupts RAD51 filaments in vitro and modulates homologous recombination in mammalian cells. J. Biol. Chem. 288, 34168–34180 (2013).
Xue, H. et al. A two-step mechanism governing PARP1–DNA retention by PARP inhibitors. Sci. Adv. 8, eabq0414 (2022).
Adamowicz, M. et al. XRCC1 protects transcription from toxic PARP1 activity during DNA base excision repair. Nat. Cell Biol. 23, 1287–1298 (2021).
Hucl, T. et al. A syngeneic variance library for functional annotation of human variation: application to BRCA2. Cancer Res. 68, 5023–5030 (2008).
Whelan, D. R. et al. Super-resolution visualization of distinct stalled and broken replication fork structures. PLoS Genet. 16, e1009256 (2020).
Whelan, D. R. & Rothenberg, E. Super-resolution mapping of cellular double-strand break resection complexes during homologous recombination. Proc. Natl Acad. Sci. USA 118, e2021963118 (2021).
Nakamura, K. et al. Proteome dynamics at broken replication forks reveal a distinct ATM-directed repair response suppressing DNA double-strand break ubiquitination. Mol. Cell 81, 1084–1099 (2021).
Li, M. & Yu, X. C. Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation. Cancer Cell 23, 693–704 (2013).
Scott, D. E. et al. A small-molecule inhibitor of the BRCA2–RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death. Cell Chem. Biol. 28, 835–847 (2021).
Noordermeer, S. M. & van Attikum, H. PARP inhibitor resistance: a tug-of-war in BRCA-mutated cells. Trends Cell Biol. 29, 820–834 (2019).
Dai, M. F. et al. Safety and hematological toxicities of PARP inhibitors in patients with cancer: a systematic review of randomized controlled trials and a pharmacovigilance analysis. Expert Rev. Anticancer Ther. 24, 613–622 (2024).
Frenel, J. S. et al. Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial. Ann. Oncol. 33, 1021–1028 (2022).
Schlacher, K. et al. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell 145, 993–993 (2011).
Cong, K. et al. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency. Mol. Cell 81, 3128–3144 (2021).
Vugic, D. et al. Replication gap suppression depends on the double-strand DNA binding activity of BRCA2. Nat. Commun. 14, 446 (2023).
Fanale, D. et al. BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: looking for the hidden meaning. Crit. Rev. Oncol. Hematol. 172, 103626 (2022).
Jimenez-Sainz, J. & Jensen, R. B. Imprecise medicine: BRCA2 variants of uncertain significance (VUS), the challenges and benefits to integrate a functional assay workflow with clinical decision rules. Genes 12, 780 (2021).
Rouleau-Turcotte, E. & Pascal, J. M. ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification. J. Biol. Chem. 299, 105397 (2023).
Beneyton, A. et al. The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors. NAR Cancer 5, zcad043 (2023).
Goehring, L. et al. Dormant origin firing promotes head-on transcription–replication conflicts at transcription termination sites in response to BRCA2 deficiency. Nat. Commun. 15, 4716 (2024).
Petropoulos, M. et al. Transcription–replication conflicts underlie sensitivity to PARP inhibitors. Nature 628, 433–441 (2024).
Dias, M. P., Moser, S. C., Ganesan, S. & Jonkers, J. Understanding and overcoming resistance to PARP inhibitors in cancer therapy. Nat. Rev. Clin. Oncol. 18, 773–791 (2021).
Appleby, R., Joudeh, L., Cobbett, K. & Pellegrini, L. Structural basis for stabilisation of the RAD51 nucleoprotein filament by BRCA2. Nat. Commun. 14, 7003 (2023).
Park, P. H. et al. Amplification of the mutation-carrying BRCA2 allele promotes RAD51 loading and PARP inhibitor resistance in the absence of reversion mutations. Mol. Cancer Ther. 19, 602–613 (2020).
Walmsley, C. S. et al. Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy. NPJ Precis. Oncol. 8, 34 (2024).
Jensen, R. Purification of recombinant 2XMBP tagged human proteins from human cells. Methods Mol. Biol. 1176, 209–217 (2014).
Carreira, A. et al. The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51. Cell 136, 1032–1043 (2009).
Pommier, Y. et al. Differential trapping of PARP1 and PARP2 by clinical PARP inhibitors. Eur. J. Cancer 48, 87–87 (2012).
Murai, J. et al. Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib. Mol. Cancer Ther. 13, 433–443 (2014).
Matta, E., Kiribayeva, A., Khassenov, B., Matkarimov, B. T. & Ishchenko, A. A. Insight into DNA substrate specificity of PARP1-catalysed DNA poly(ADP-ribosyl)ation. Sci. Rep. 10, 3699 (2020).
Bryant, H. E. et al. PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination. EMBO J. 28, 2601–2615 (2009).
Eustermann, S. et al. The DNA-binding domain of human PARP-1 interacts with DNA single-strand breaks as a monomer through its second zinc finger. J. Mol. Biol. 407, 149–170 (2011).
Rudolph, J., Mahadevan, J., Dyer, P. & Luger, K. Poly(ADP-ribose) polymerase 1 searches DNA via a ‘monkey bar’ mechanism. eLife 7, e37818 (2018).
Shao, Z. et al. Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo. Nucleic Acids Res. 48, 9694–9709 (2020).
Lahiri, S. & Jensen, R. B. DNA strand exchange to monitor human RAD51-mediated strand invasion and pairing. Methods Mol. Biol. 2153, 101–113 (2021).
Hellenkamp, B. et al. Precision and accuracy of single-molecule FRET measurements—a multi-laboratory benchmark study. Nat. Methods 15, 669–676 (2018).
Bronson, J. E., Fei, J. Y., Hofman, J. M., Gonzalez, R. L. & Wiggins, C. H. Learning rates and states from biophysical time series: a Bayesian approach to model selection and single-molecule FRET data. Biophys. J. 97, 3196–3205 (2009).
van de Meent, J. W., Bronson, J. E., Wiggins, C. H. & Gonzalez, R. L. Empirical Bayes methods enable advanced population-level analyses of single-molecule FRET experiments. Biophys. J. 106, 1327–1337 (2014).
van de Meent, J. W., Bronson, J. E., Wood, F., Gonzalez, R. L. Jr. & Wiggins, C. H. Hierarchically-coupled hidden Markov models for learning kinetic rates from single-molecule data. JMLR Workshop Conf. Proc. 28, 361–369 (2013).
Cui, T. J. et al. Argonaute bypasses cellular obstacles without hindrance during target search. Nat. Commun. 10, 4390 (2019).
Gotz, M. et al. A blind benchmark of analysis tools to infer kinetic rate constants from single-molecule FRET trajectories. Nat. Commun. 13, 5402 (2022).
Jensen, R. B., Ozes, A., Kim, T., Estep, A. & Kowalczykowski, S. C. BRCA2 is epistatic to the RAD51 paralogs in response to DNA damage. DNA Repair 12, 306–311 (2013).
Coleman, K. E. et al. USP1-trapping lesions as a source of DNA replication stress and genomic instability. Nat. Commun. 13, 1740 (2022).
Yin, Y. & Rothenberg, E. Probing the spatial organization of molecular complexes using triple-pair-correlation. Sci. Rep. 6, 30819 (2016).
Lee, W. T. C. et al. Single-molecule imaging reveals replication fork coupled formation of G-quadruplex structures hinders local replication stress signaling. Nat. Commun. 12, 2525 (2021).
Pinkard, H. et al. Pycro-Manager: open-source software for customized and reproducible microscope control. Nat. Methods 18, 226–228 (2021).
Yin, Y. D., Lee, W. T. C. & Rothenberg, E. Ultrafast data mining of molecular assemblies in multiplexed high-density super-resolution images. Nat. Commun. 10, 119 (2019).
Huang, F. et al. Video-rate nanoscopy using sCMOS camera-specific single-molecule localization algorithms. Nat. Methods 10, 653–658 (2013).
Huang, F., Schwartz, S. L., Byars, J. M. & Lidke, K. A. Simultaneous multiple-emitter fitting for single molecule super-resolution imaging. Biomed. Opt. Express 2, 1377–1393 (2011).
Sengupta, P. et al. Probing protein heterogeneity in the plasma membrane using PALM and pair correlation analysis. Nat. Methods 8, 969–975 (2011).
Holden, S. J., Uphoff, S. & Kapanidis, A. N. DAOSTORM: an algorithm for high-density super-resolution microscopy. Nat. Methods 8, 279–280 (2011).
Ovesny, M., Krizek, P., Borkovec, J., Svindrych, Z. K. & Hagen, G. M. ThunderSTORM: a comprehensive ImageJ plug-in for PALM and STORM data analysis and super-resolution imaging. Bioinformatics 30, 2389–2390 (2014).
Rothenberg, E. BRCA2 prevents PARPi-mediated PARP1 retention to protect RAD51 filaments. Zenodo https://doi.org/10.5281/zenodo.14713371 (2025)
Source link
Add a Comment